ReviewInflammopharmacology2025
Targeting rheumatoid arthritis risk factors with phytochemicals: an anti-inflammatory perspective.
Review in Inflammopharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Integration of phytochemical profiling and pharmacological assessment of Eucalyptus salubris seeds: a promising natural anti-inflammatory agent.Inflammopharmacology · 2026Article
- From Activity Screening to Quality Control: UHPLC-MS/MS Analysis of Anti-Inflammatory Cyclodipeptides inMolecules (Basel, Switzerland) · 2026Article
- Effects of Pelargonium sidoides root extract on paw oedema, nitric oxide signaling, and synovial vascular changes in a rat model of adjuvant-induced arthritis.Inflammopharmacology · 2026Article
- Association of life's essential 8 and genetic predisposition with the risk of osteoarthritis: a prospective cohort study.Frontiers in nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammation is a fundamental immunological response to external stimuli or damage caused by pathogens. Inflammatory disorders can be categorized to acute or chronic joint diseases. Rheumatoid arthritis (RA) is classified as an inflammatory disorder, whereas osteoarthritis (OA) does not exhibit overt inflammatory characteristics compared to those of RA; however, certain inflammatory cytokines and episodic inflammation have been implicated in the progression of OA. This review enumerates how biological factors trigger the activation of Inflammasomes followed by series of inter-related processes. Latest literature revealed the management of arthritis requires comprehensive and multidimensional strategies. Although plethora of conventional anti-arthritic agents have been utilized to alleviate the manifestations of arthritis. Yet, their efficacy and tolerability may be compromised with human health while reviewing the documented adverse effects. Hence, an urgent priority is to investigate complementary and alternative therapeutic modalities, specifically traditional medicine, medicinal flora, and their associated phytochemicals. These demonstrate considerable anti-inflammatory properties with diminished adverse effects on human health. The current review aims to consolidate information regarding such promising medicinal plants and naturally occurring bioactive compounds that exhibit anti-inflammatory effects against arthritis, as evidenced by various in vitro, in vivo, and other preclinical as well as clinical investigations, thereby aiding researchers in the development of phytomedicinal therapies for arthritis.
Indexed as
Identifiers
40591213What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.